SBIR/STTR Research Award

Gene Enhanced Tissue Engineering for Bone Regeneration

Award identifier 882001ce9accc05e638ca9c91e8ef99a8ae00d928d1eae47f31ca4f4b967b26bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,509

Program and phase

STTR · Phase I

Award year

2004

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
TISSUEGENESIS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The development of novel and improved technologies for bone regeneration is desirable in many clinical applications, especially in dental and craniofacial reconstruction and fracture repair. Optimal bone regeneration requires the interaction of three components at the site of injury. These include: the presence of appropriate cell type(s) with bone regenerative capacity, a suitable matrix for cellular attachment, and local presence of regulatory proteins orchestrating the bone regenerative process. The gene-enhanced tissue engineering approach to bone regeneration incorporates all three components at the site of injury. Bone regenerative cells that secrete regulatory proteins of known importance in bone regeneration are combined in a three-dimensional matrix such that a gene enhanced cell based composite having both osteoconductive and osteoinductive properties is delivered to the site for optimal bone regeneration. The first specific aim is to directly evaluate in a calvarial bone defect model the bone regenerative capacity of three cell populations of reported importance in the bone regenerative process. The three cell sources include periosteal-derived mesenchymal stem cells, fat-derived stem cells, and gingival fibroblasts. The second aim is to assess the bone regenerative potential of Sonic hedgehog (Shh), a potent regulatory protein important in craniofacial morphogenesis. Cells will be stably transduced with control and Shh expressing retroviral vectors to obtain Shh expressing cell populations. Eight mm calvarial defects will be made in skeletally mature NZW rabbits. Non-, control-, and Shh-transduced allogenic cells of the three types will be delivered to the defects in a composite matrix composed of alginate and collagen I. Additional controls include empty defects and alginate/collagen I alone. Bone regeneration will be quantitated radiographically and histologically. Animals will be sacrificed after 6 and 12 weeks. Regeneration will be quantitated histologically by measuring the area of new bone in several representative cross sections to assess both thickness and closure of regenerated bone.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.